ATF4 and glioblastoma: Here, we describe the discovery of a novel class of small molecule GPR68/OGR-1 inhibitors named ogremorphins, and using this class, we show that GPR68-ATF4 signaling is a novel glioblastoma pro-survival pathway activated in an autocrine manner by extracellular protons.